MathewWMacCumberMDPhD
Ophthalmology • Harvey, ILRetinal Disease
Professor, Ophthalmology, Rush Medical College of Rush University
Dr. MacCumber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
71 W 156th St
Ste 400
Harvey, IL 60426Phone+1 708-596-8710Fax+1 708-596-9820- Is this information wrong?
Summary
- Dr. Mathew MacCumber is an ophthalmologist in Oak Park, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center, Rush Oak Park Hospital, AMITA Health Saint Joseph Hospital, Skokie Hospital, Advocate Illinois Masonic Medical Center, Glenbrook Hospital, Highland Park Hospital, AMITA Health Saints Mary & Elizabeth Medical Center Chicago, and Captain James A. Lovell Federal Health Care Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 29 years. He specializes in retinal disease and is experienced in cataract surgery, retina surgery, and vitreoretinal disease.
Education & Training
Johns Hopkins UniversityResidency, Ophthalmology, 1991 - 1994
MedStar Franklin Square Medical CenterInternship, Internal Medicine, 1990 - 1991- Johns Hopkins University School of MedicineClass of 1988
Certifications & Licensure
IL State Medical License 1996 - 2026
CA State Medical License 2021 - 2025
NC State Medical License 1994 - 1998
MD State Medical License 1993 - 1997- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging Start of enrollment: 2008 Jan 01
- PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry.Helene Karcher, Eser Adiguzel, Andrew Mayhook, Andrew LaPrise, Ver L Bilano, Franklin Igwe, Marco A Zarbin, Mathew W MacCumber, Michael S Ip, Charles C Wykoff> ;Ophthalmology and Therapy. 2024 Mar 23
- Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40.Danni Liu, Maureen G Maguire, Adam R Glassman, Lee M Jampol, Ronald M Kingsley, Daniel F Martin, Raj K Maturi, Gisela Velez, Jennifer K Sun, , Chirag D Jhaveri, Ruben ...> ;Ophthalmology. 2024 Feb 8
- Long-Term Control of Retinal Thickness Variability and Vision Following the 0.19 mg Fluocinolone Acetonide Implant.Veeral S Sheth, Michael Singer, Mathew MacCumber, Antonio Cutino, Jonathan Kasper, Brandon A Coughlin, Christopher D Riemann> ;Journal of Vitreoretinal Diseases. 2023 Oct 3
- Join now to see all
Press Mentions
Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society MeetingFebruary 8th, 2021
Update on Retinal Research with the IRIS RegistryOctober 1st, 2018
Professional Memberships
- Fellow
Hospital Affiliations
Rush University Medical CenterChicago, Illinois
Rush Oak Park HospitalOak Park, Illinois
AMITA Health Saint Joseph HospitalChicago, Illinois
Skokie HospitalSkokie, Illinois
Advocate Illinois Masonic Medical CenterChicago, Illinois
Glenbrook HospitalGlenview, Illinois
Highland Park HospitalHighland Park, Illinois
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
